Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study to Evaluate the Long-Term Efficacy and Safety of LIB003 in Patients With Cardiovascular Disease on Stable Lipid-Lowering Therapy Requiring Additional LDL-C Reduction

NCT04797247 is registered in ClinicalTrials.gov with LIB Therapeutics LLC as lead sponsor.

NCT NCT04797247
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04797247 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study to Evaluate the Long-Term Efficacy and Safety of LIB003 in Patients With Cardiovascular Disease on Stable Lipid-Lowering Therapy Requiring Additional LDL-C Reduction
Lead sponsor
LIB Therapeutics LLC
Phase
Phase 3
Overall status
Unknown status
Start date
April 22, 2021
Completion date
February 28, 2024
Enrollment
900 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, hyper-ldl-cholesterolemia